Please assess the completion status of the following clinical trial:

Trial Title: Microwave Coagulation in Partial Nephrectomy Protocol

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Patient must have a solitary, polar, clinical T1 renal mass~2. Patient must have adequate kidney function as measured by eGFR (estimated glomerular filtration rate) greater than or equal to 50 calculated from a standard care serum creatinine performed within 30 days prior to the partial nephrectomy operation.~3. Women of child-bearing potential must have negative serum or urine pregnancy test~4. Patient must be able to give written informed consent~5. Patient must be 18 years or older~6. No blood-thinning medications, including anti-inflammatory medications, herbs and supplements for at least 1 week prior to surgery~Exclusion Criteria:~1. T stage greater than clinical T1~2. Tumor extends beyond kidney into major veins, perinephric tissues, or adrenal gland~3. Prior surgery or radiation therapy to the region of interest~4. Patient has a single functioning kidney~5. Patient has an uncorrectable coagulopathy~6. Patient is not a surgical candidate due to underlying cardiac or other serious comorbid condition

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Certus 140™ (Type: EXPERIMENTAL): During the operation: use of Certus 140™ microwave device for pre-coagulation of the kidney tissue adjacent to the tumor.

Based on this trial design, predict the completion outcome and termination type (if applicable).